AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 50 filers reported holding AGEX THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,225 | -23.9% | 26,801 | 0.0% | 0.00% | – |
| Q2 2023 | $23,939 | +34.7% | 26,801 | 0.0% | 0.00% | – |
| Q1 2023 | $17,769 | -39.9% | 26,801 | -50.0% | 0.00% | – |
| Q4 2022 | $29,582 | +97.2% | 53,602 | +100.0% | 0.00% | – |
| Q3 2022 | $15,000 | 0.0% | 26,801 | 0.0% | 0.00% | – |
| Q2 2022 | $15,000 | -34.8% | 26,801 | -0.2% | 0.00% | – |
| Q1 2022 | $23,000 | -20.7% | 26,861 | 0.0% | 0.00% | – |
| Q4 2021 | $29,000 | +16.0% | 26,861 | 0.0% | 0.00% | – |
| Q3 2021 | $25,000 | -40.5% | 26,861 | 0.0% | 0.00% | – |
| Q2 2021 | $42,000 | -84.6% | 26,861 | -90.9% | 0.00% | – |
| Q1 2020 | $273,000 | -42.9% | 293,888 | +11.8% | 0.00% | – |
| Q4 2019 | $478,000 | -3.0% | 262,790 | +4.5% | 0.00% | – |
| Q3 2019 | $493,000 | -22.7% | 251,522 | +44.6% | 0.00% | – |
| Q2 2019 | $638,000 | -19.7% | 173,941 | -11.4% | 0.00% | – |
| Q1 2019 | $795,000 | +13.7% | 196,398 | -16.0% | 0.00% | – |
| Q4 2018 | $699,000 | – | 233,764 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 2,997,156 | $1,654,130 | 0.14% |
| Strategic Wealth Investment Group, LLC | 86,440 | $60,516 | 0.01% |
| Prescott General Partners LLC | 185,185 | $102,204 | 0.01% |
| Summit X, LLC | 33,000 | $19,015 | 0.01% |
| Beirne Wealth Consulting Services, LLC | 18,000 | $9,934 | 0.01% |
| Sigma Planning Corp | 134,977 | $74,494 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 169,770 | $93,696 | 0.00% |
| UBS Group AG | 13,502 | $7,426 | 0.00% |
| NewEdge Advisors, LLC | 1 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 334 | $184 | 0.00% |